Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 366

The DOI matches its Crossref record; 386 of the 386 references it cites were found in a registry or an index.

Sex differences in cancer mechanisms

Open access
Rubin, Joshua B., Lagas, Joseph S., Broestl, Lauren, Sponagel, Jasmin, Rockwell, Nathan, Rhee, Gina, Rosen, Sarah F., Chen, Si, Klein, Robyn S., Imoukhuede, Princess, Luo, Jingqin·2020·Biology of Sex Differences

Abstract

We now know that cancer is many different diseases, with great variation even within a single histological subtype. With the current emphasis on developing personalized approaches to cancer treatment, it is astonishing that we have not yet systematically incorporated the biology of sex differences into our paradigms for laboratory and clinical cancer research. While some sex differences in cancer arise through the actions of circulating sex hormones, other sex differences are independent of estrogen, testosterone, or progesterone levels. Instead, these differences are the result of sexual differentiation, a process that involves genetic and epigenetic mechanisms, in addition to acute sex hormone actions. Sexual differentiation begins with fertilization and continues beyond menopause. It affects virtually every body system, resulting in marked sex differences in such areas as growth, lifespan, metabolism, and immunity, all of which can impact on cancer progression, treatment response, and survival. These organismal level differences have correlates at the cellular level, and thus, males and females can fundamentally differ in their protections and vulnerabilities to cancer, from cellular transformation through all stages of progression, spread, and response to treatment. Our goal in this review is to cover some of the robust sex differences that exist in core cancer pathways and to make the case for inclusion of sex as a biological variable in all laboratory and clinical cancer research. We finish with a discussion of lab- and clinic-based experimental design that should be used when testing whether sex matters and the appropriate statistical models to apply in data analysis for rigorous evaluations of potential sex effects. It is our goal to facilitate the evaluation of sex differences in cancer in order to improve outcomes for all patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13293-020-00291-x

Cites

386 of 386 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 386 references

Research works printed but not linked: 19

  1. Rampen FH. Malignant melanoma: sex differences in response to chemotherapy? Eur J Cancer Clin Oncol. 1982;18:107–10. · doi:10.1016/0277-5379(82)90033-5
  2. Farahati, J., Bucsky, P., Parlowsky, T., Mader, U. & Reiners, C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 80, 2156-2162, doi:10.1002/(sici)1097-0142(19971201)80:11 < 2156::aid-cncr16 > 3.0.co;2-y (1997). · doi:10.1002/(sici)1097-0142(19971201)80:11
  3. Lautrup, M. D. et al. Male breast cancer: a nation-wide population-based comparison with female breast cancer. Acta Oncol 57, 613-621, doi:10.1080/0284186X.2017.1418088 (2018). · doi:10.1080/0284186x.2017.1418088
  4. Muscat, JE. & Wynder, EL. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer 69, 2244-2251, doi:10.1002/1097-0142(19920501)69:9 < 2244::aid-cncr2820690906 > 3.0.co;2-o (1992). · doi:10.1002/1097-0142(19920501)69:9
  5. Polednak, AP. & Flannery, JT. Brain, other central nervous system, and eye cancer. Cancer 75, 330-337, doi:10.1002/1097-0142(19950101)75:1 + <330::aid-cncr2820751315 > 3.0.co;2-5 (1995). · doi:10.1002/1097-0142(19950101)75:1
  6. Swango PA. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent. 1996;56:309–18. · doi:10.1111/j.1752-7325.1996.tb02458.x
  7. Tota JE, et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral Oncol. 2017;67:146–52. https://doi.org/10.1016/j.oraloncology.2017.02.019. · doi:10.1016/j.oraloncology.2017.02.019
  8. Franceschi E, et al. The prognostic roles of gender and O6-methylguanine-DNA methyltransferase methylation status in glioblastoma patients: the female power. World Neurosurg. 2018;112:e342–7. https://doi.org/10.1016/j.wneu.2018.01.045. · doi:10.1016/j.wneu.2018.01.045
  9. Zhu J, Kong F, Xing L, Jin Z, Li Z. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer. Clin Chim Acta. 2018;479:43–7. https://doi.org/10.1016/j.cca.2018.01.005. · doi:10.1016/j.cca.2018.01.005
  10. Jin M, et al. Long noncoding RNA JPX correlates with poor prognosis and tumor progression in non-small cell lung cancer by interacting with miR-145-5p and CCND2. Carcinogenesis. 2019. https://doi.org/10.1093/carcin/bgz125. · doi:10.1093/carcin/bgz125
  11. Yang F, et al. Identifying potential metastasis-related long non-coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinoma. J Cell Biochem. 2019;120:13202–15. https://doi.org/10.1002/jcb.28594. · doi:10.1002/jcb.28594
  12. Menezo YJ, Chouteau J, Torello J, Girard A, Veiga A. Birth weight and sex ratio after transfer at the blastocyst stage in humans. Fertil Steril. 1999;72:221–4. https://doi.org/10.1016/s0015-0282(99)00256-3. · doi:10.1016/s0015-0282(99)00256-3
  13. Peippo J, Kurkilahti M, Bredbacka P. Developmental kinetics of in vitro produced bovine embryos: the effect of sex, glucose and exposure to time-lapse environment. Zygote. 2001;9:105–13. · doi:10.1017/s0967199401001113
  14. Williams TJ. A technique for sexing mouse embryos by a visual colorimetric assay of the X-linked enzyme, glucose 6-phosphate dehydrogenase. Theriogenology. 1986;25:733–9. · doi:10.1016/0093-691x(86)90131-7
  15. van den Akker, CH., te Braake, FW., Weisglas-Kuperus, N. & van Goudoever, JB. Observational outcome results following a randomized controlled trial of early amino acid administration in preterm infants. J Pediatr Gastroenterol Nutr 59, 714-719, doi:10.1097/MPG.0000000000000549 (2014). · doi:10.1097/mpg.0000000000000549
  16. Krzymowski T, Stefanczyk-Krzymowska S. Advances in understanding the physiological mechanism of maternal immune tolerance to the embryo. Reprod Biol. 2012;12:265–70. https://doi.org/10.1016/j.repbio.2012.10.004. · doi:10.1016/j.repbio.2012.10.004
  17. Krauthacker B. Levels of organochlorine pesticides and polychlorinated biphenyls (PCBs) in human milk and serum collected from lactating mothers in the northern Adriatic area of Yugoslavia. Bull Environ Contam Toxicol. 1991;46:797–802. https://doi.org/10.1007/bf01689721. · doi:10.1007/bf01689721
  18. Kim KH, Young BD, Bender JR. Endothelial estrogen receptor isoforms and cardiovascular disease. Mol Cell Endocrinol. 2014;389:65–70. https://doi.org/10.1016/j.mce.2014.02.001. · doi:10.1016/j.mce.2014.02.001
  19. Linderholm B, Tavelin B, Grankvist K, Henriksson R. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? Br J Cancer. 1999;81:727–32. https://doi.org/10.1038/sj.bjc.6690755. · doi:10.1038/sj.bjc.6690755

Cited by

See all 366

Metadata

Authors
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., & Luo, J.
Venue
Biology of Sex Differences
Published
2020-04-15
Volume
11
Issue
1
Pages
17-17
ISSN
2042-6410 (ISSN-L)
OpenAlex
W3016662185
Cited by
366
References
386
FWCI
33.21
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • National Cancer Institute (CA174737)
  • Children's Discovery Institute (N/A)
  • Prayers from Maria (N/A)
  • St Louis Children's Hospital Foundation (N/A)
  • Foundation for Barnes-Jewish Hospital (N/A)
  • Barnard Research Funds (N/A)
  • Joshua's Great Things (N/A)
  • National Institutes of Health (U19 AI083019, R01 NS052632, R01 AI101400)
  • National Society for Multiple Sclerosis (N/A)
  • National Science Foundation (1653925)
  • American Heart Association (16SDG26940002)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex differences in cancer mechanisms. https://app.cochat.ai/papers/10.1186/s13293-020-00291-x
The paper
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., & Luo, J. (2020). Sex differences in cancer mechanisms. Biology of Sex Differences. https://doi.org/10.1186/s13293-020-00291-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.